Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hana Micron (067310) – Setting of Closure Period of Shareholders’ Register or Record Date / 2024-12-16

Posted on August 2, 2026August 2, 2026 By K-STOCK Editor No Comments on [Disclosure] Hana Micron (067310) – Setting of Closure Period of Shareholders’ Register or Record Date / 2024-12-16

Fact Source: Financial Supervisory Service DART

💡 Executive Summary

Hana Micron set December 31, 2024, as the record date to determine shareholders entitled to exercise voting rights at the 24th Annual General Meeting of Shareholders.

📊 Key Disclosure Content & Financial Figures Summary

  1. Company Name: Hana Micron Inc.
  2. Record Date Details:
    • Record Date: December 31, 2024
    • Closure Period for Entry of Change (Start Date / End Date): Not stated (pursuant to the Act on Electronic Registration of Stocks, Bonds, Etc.)
  3. Purpose: Determination of eligible shareholders for holding the 24th Annual General Meeting of Shareholders
  4. Board Resolution Date: December 13, 2024
  5. Other References for Investment Decision:
    • Pursuant to Article 17 (Closure of Shareholders’ Register and Record Date) of the Articles of Incorporation.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Record Date Filing and Annual General Meeting Notices

This filing announces the establishment of the record date (December 31, 2024) for voting rights at the 24th Annual General Meeting of Shareholders. Checking the record date set for exercising voting rights is important for tracking upcoming shareholder meeting schedules and proposals. Further details can be verified through future official disclosures, such as the Board Resolution on AGM Convening, AGM Notices, and Annual Reports.

📢 Disclaimer & Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.

Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Daeduck Electronics (353200) – Provisional Operating Results (Consolidated Financial Basis) / 2026-07-31
Next Post: [Disclosure] Hanwha Ocean (042660) – Execution of Sales / Supply Contract / 2026-08-03

Related Posts

[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-09-09 Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15 Semiconductors
[Disclosure] Hanwha Ocean (042660) – Results of Annual General Meeting of Shareholders / 2026-03-19 Disclosures
[Disclosure] Hanwha Systems (272210) Decides FY2024 Year-End Cash Dividend: KRW 350 per Common Share, Totaling KRW 65.45B Disclosures
[Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding / 2026-05-20 Semiconductors
[Disclosure] Hanwha Systems (272210) Signs KRW 112.3B Supply Contract with DAPA for K2 Tank Fire Control System PBL and 3 Other Items Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme